Audit of eligibility of hepatitis C/HIV co-infected patients in the Lothian Regional Infectious Diseases Unit cohort for new HCV protease inhibitor containing regimens
Presentation / Conference
Devine, K., Whiteley, D., & Leen, C. Audit of eligibility of hepatitis C/HIV co-infected patients in the Lothian Regional Infectious Diseases Unit cohort for new HCV protease inhibitor containing regimens

Background: Introduction of the new HCV protease inhibitors has been shownto improve outcomes for mono-infected patients. Recent data showssignificant decline in HCV RNA at 24 weeks in genotype 1 co-infectedpatients on HAART who received either Telap... Read More about Audit of eligibility of hepatitis C/HIV co-infected patients in the Lothian Regional Infectious Diseases Unit cohort for new HCV protease inhibitor containing regimens.